Graduation Year

2015

Document Type

Thesis

Degree

M.S.

Degree Name

Master of Science (M.S.)

Department

Chemistry

Degree Granting Department

Chemistry

Major Professor

Bill Baker, Ph.D.

Committee Member

Edward Turos, Ph.D.

Committee Member

Wayne Guida, Ph.D.

Committee Member

Lindsey Shaw, Ph.D.

Keywords

Natural products, diketopiperazine, secondary metabolites, cross-talk

Abstract

New methodology has been utilized to provoke or increase targeted metabolic pathways in microbes. The low hanging fruit of natural products has been discovered over the last 50 years. To continue finding new metabolites to be used as possible drug candidates, methodology development such as those proposed herein are necessary. This methodology uses extracts from known pathogenic bacteria to elicit production of latent biosynthetic pathways from environmental bacterial isolates that may be active against the original pathogenic strains. A new compound, MAV-1 (1) of the diketopiperazine family (Figure 1) was isolated and identified utilizing these techniques. The structure of MAV-1 (1) was defined by a combination of mass spectroscopy (MS) and nuclear magnetic resonance (NMR) spectroscopy. Discovery of MAV-1 (1), a possible precursor to other known compounds, demonstrates the continuing utility of microbial sources with new chemodiversity.

Included in

Chemistry Commons

Share

COinS